Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
- DOI
- 10.1016/j.ejca.2021.08.027
- Published
- 2021 Nov
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2021.08.027,
title = {Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.},
author = {Aramaki O and Takayama T and Moriguchi M and Sakamoto H and Yodono H and Kokudo N and Yamanaka N and Kawasaki S and Sasaki Y and Kubota K and Otsuji E and Tanaka S and Matsuyama Y and Fujii M and ACE 500 study group},
year = {2021},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2021.08.027},
url = {https://doi.org/10.1016/j.ejca.2021.08.027}
}RIS
TY - JOUR TI - Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial. AU - Aramaki O AU - Takayama T AU - Moriguchi M AU - Sakamoto H AU - Yodono H AU - Kokudo N AU - Yamanaka N AU - Kawasaki S AU - Sasaki Y AU - Kubota K AU - Otsuji E AU - Tanaka S AU - Matsuyama Y AU - Fujii M AU - ACE 500 study group PY - 2021 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2021.08.027 UR - https://doi.org/10.1016/j.ejca.2021.08.027 ER -
APA
O, A., T, T., M, M., H, S., H, Y., N, K., N, Y., S, K., Y, S., K, K., E, O., S, T., Y, M., M, F., & group, A. 5. S. (2021). Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2021.08.027
Source records
- pubmed · retrieved 2026-09-26T16:04:34.979Z